Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Forest Wins Lexapro Patent Fight | Contract Pharma

What are you searching for?

Sign in
Breaking News

Forest Wins Lexapro Patent Fight

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

The U.S. District Court for the District of Delaware has determined that Forest Laboratories‘ patent covering escitalopram, the active ingredient in Lexapro, is both valid, enforceable and infringed by Ivax/Teva’s proposed generic product. The ruling confirms patent rights for Lexapro, which expire in March 2012, for Forest and its partner H. Lundbeck A/S of Denmark.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters